RSS
Translated by

The center of electron beam processing of medical products in Dubna

Company

Content

Owners

History

2019: Declaration of construction of the center

At the end of November, 2019 the Akcentre management company, producer of the medical products "Pomegranate Biot Tekh", a medico-technical cluster of the Moscow region and the management of the Dubna special economic zone (SEZ) signed the agreement on creation of the Center of electron beam processing of medical products.

Invest 435.8 million rubles in the project. The center of sterilization of medical products will open in Dubna in October, 2020. It will receive the accelerator of electrons with a power of 10-20 kW which, as expected, will allow to process up to 12 thousand tons of medical products annually.

Signed the agreement on creation of the Center of electron beam processing of medical products

In a conversation with the Vademecum edition the CEO of UK "Akcentre" Dmitry Rudash said that the center of sterilization of medical products should satisfy fully needs of the acting and future participants of a cluster for disinfection of products which are turned out by them.

As of November 27, 2019 creation of the center already is well under way — the workshop is under construction. Initiators want to start at the enterprise an add-on unit of sterilization by ethylene oxide for medical products which do not suit disinfection. It is supposed that in the center about 55 people will work.

Akcentr notes that the center sterilization of disposable products of medical appointment will allow the Russian producers not only from the Moscow region, but also adjacent regions in short terms to process necessary volumes of these products and also to sell the potential of substitution of import medical products existing in the market. Over time, having available sterilizing infrastructure, ISO-certified 13485 recognized world leaders in this sphere, the Moscow region will increase the attractiveness for localization of the enterprises of foreign producers here, consider in the company.< [1]

Notes